Clinical Trial

Ankylosing Spondylitis

Study acronym: Interleukins
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to measure the serum level of cytokines IL-17, IL-38,IL-41, and gene expression of HLA-B27 gene in ankylosing spondylitis patients and healthy control group. The main question it aims to answer is: Does the disease activity, severity, serum level of cytokines (IL-17, IL-38, and IL-41) are affected by the HLA-b27 gene positivity? Researchers will compare the serum level of cytokines IL-17, IL-38,IL-41, and gene expression of HLA-B27 gene in ankylosing spondylitis patients and healthy control group to see if there significant differences in serum levels of interleukins 17, 38, 41 in AS patients and healthy control group. .
Trial Details
NCT Number NCT07396194
Lead Sponsor Sohag University
Conditions Ankylosing Spondylitis
Enrollment 84 participants
Start Date 2026-03-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-09